Skip to main content
S.M.A.I.O logo

S.M.A.I.O — Investor Relations & Filings

Ticker · ALSMA ISIN · FR0014005I80 LEI · 969500T1Z0DAZXPZMC93 PA Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2023-01-17 Earnings Release
Country FR France
Listing PA ALSMA

About S.M.A.I.O

https://smaio.com/

S.M.A.I.O. (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer that develops solutions for spine surgery. The company provides a comprehensive platform, I-Kontrol, which incorporates planning software, adaptive implants, and related services for spine surgeons. This integrated solution is designed to enhance control over surgical procedures to improve safety, performance, and repeatability. The I-Kontrol platform covers the entire surgical workflow, including pre-operative planning (i-PLAN), surgical execution with implants (i-PERFORM), post-operative outcome analysis (i-CHECK), and training programs (i-LEARN). S.M.A.I.O. utilizes clinical data, imaging, and artificial intelligence to advance the treatment of vertebral conditions.

Recent filings

Filing Released Lang Actions
Inside Information / Information on annual revenues
Earnings Release Classification · 1% confidence The document explicitly states it 'today published its annual sales for the year to December 31, 2022.' It provides key financial figures (€2,442k sales, breakdown by France/International) and highlights from the year, along with a CEO quote. This content structure—a press release announcing preliminary or unaudited annual sales figures—is characteristic of an Earnings Release (ER) or a preliminary announcement preceding the full Annual Report (10-K). Since it focuses on the immediate release of period-end sales figures and highlights, it fits the definition of an Earnings Release (ER) better than the comprehensive 10-K, which is typically filed later and contains audited statements and extensive MD&A. It is not a full transcript (CT), a formal audit report (AR), or a proxy statement (PSI). The document is substantial enough (over 7,000 characters) that it is not merely a Report Publication Announcement (RPA). FY 2022
2023-01-17 English
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 1% confidence The document is a press release published on January 17, 2023, detailing the company's revenue ('chiffre d'affaires') for the fiscal year ending December 31, 2022. It presents key financial figures (revenue growth, international sales breakdown) and highlights significant business events from 2022, while also providing a forward-looking statement and announcing the date for the full 'Résultats annuels 2022' (April 12, 2023). This structure—a summary of period results released before the comprehensive annual filing—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) nor a comprehensive Interim Report (IR), but the initial announcement of the period's financial performance. FY 2022
2023-01-17 French
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "Agenda financier 2023" and explicitly lists the indicative financial calendar for the year 2023, including dates for annual results, AGM, and interim results. It is not the actual financial report (like 10-K or IR), nor is it a transcript or a specific regulatory filing about a single event. It is an announcement detailing *when* future reports and meetings will occur. This fits best under the category of an announcement regarding the publication or scheduling of company reports and events, which aligns closely with 'Report Publication Announcement' (RPA) or a general 'Regulatory Filing' (RNS). Since it specifically announces the schedule for key financial events and the AGM, RPA is the most precise fit, as it announces the publication schedule for reports (Annual Results, H1 Results) and the AGM date.
2023-01-12 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is titled '2023 financial calendar' and lists indicative dates for future corporate events, specifically mentioning '2022 full-year results', 'Annual General Meeting', and '2023 first-half results'. This is an announcement detailing the schedule of future financial reporting and shareholder meetings, rather than the reports themselves. Since it is an announcement about future reports and meetings, it fits best under the category for announcing report publications or general regulatory updates. Given the specific mention of the Annual General Meeting date, it relates to corporate governance scheduling. However, the primary function is to communicate the schedule of future financial events. This is not a specific financial report (like 10-K or ER), nor is it a proxy statement (PSI) or AGM material (AGM-R) yet. It is an announcement about when these events will occur. The closest fit among the options for an announcement detailing the schedule of future financial/corporate events is often a general regulatory announcement or a report publication announcement. Since it explicitly lists the date for the 'Annual General Meeting', and the document is short and serves as a notification, 'Report Publication Announcement' (RPA) is a strong candidate as it announces the timing of future publications. Alternatively, since it is a calendar of events, it could be seen as a general regulatory filing (RNS). Given the context of announcing the schedule for financial results and the AGM, RPA is slightly more specific than RNS, but RNS is the general fallback for announcements. Since the document is a calendar of future events, and not the actual report, RPA (Report Publication Announcement) is appropriate as it announces *when* reports will be published. If RPA is interpreted strictly as announcing the publication of an *already prepared* report, RNS (Regulatory Filings) might be safer as a general announcement. However, since it announces the schedule for the AGM and results, which are major corporate events, RPA seems fitting for scheduling announcements. I will select RPA as it announces the publication schedule for key reports.
2023-01-12 English
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Capital/Financing Update Classification · 1% confidence The document is titled "Bilan semestriel du Contrat de Liquidité contracté avec TP ICAP" (Semi-annual balance sheet of the Liquidity Contract entered into with TP ICAP) and is dated January 3, 2023, reporting data as of December 30, 2022. It details the holdings (shares and cash) and transactions (buy/sell) related to a liquidity contract over the second half of 2022. This type of regular, periodic disclosure regarding market making or liquidity provision activities, especially when presented as a 'Bilan semestriel' (Semi-annual report), is a specific type of regulatory or market-related announcement. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard Interim Report (IR) which focus on operational/financial performance. It is a specific disclosure about market operations. Given the options, this disclosure relates to the company's interaction with the market and its share structure/trading, but it is most closely aligned with a specific regulatory disclosure or a specialized financial update. Since it is a formal, periodic report on a specific financial arrangement (liquidity contract), and not a general announcement of a report's publication (RPA), it fits best under a specific regulatory/market disclosure category. However, none of the codes perfectly match 'Liquidity Contract Disclosure'. It is a periodic report detailing market activity. If we look at the definitions, it is not a Director's Dealing (DIRS), nor a Major Shareholding Notification (MRQ). It is a formal report on a financial arrangement. In the context of French market practices, these are often filed as regulatory updates. Since it is a formal, periodic report detailing specific financial/market data, and not a general earnings or comprehensive financial statement, it is best classified as a Regulatory Filing (RNS) as a specific disclosure that doesn't fit the other precise categories, or potentially a specialized financial update. Given the detailed transactional data provided, it is more than just a brief announcement. However, it is not a comprehensive financial report (10-K or IR). It is a specific disclosure about market operations. I will classify it as RNS (Regulatory Filings) as the most appropriate fallback for a specific, non-standard periodic disclosure, although it shares characteristics with other updates. Upon re-evaluation, this document is a formal, periodic disclosure about the liquidity agreement, which is a specific corporate action/arrangement. It is not a general regulatory filing (RNS) unless it is mandated by the exchange. Since it details share transactions related to market making, it is a specific market-related disclosure. Given the options, RNS is the safest fallback for specific, non-core financial disclosures. I will assign a high confidence score due to the clear nature of the content, even if the category mapping is imperfect.
2023-01-03 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release dated November 17, 2022, announcing the success of SMAIO's first educational program in the United States. It details a training session for US surgeons on their spinal surgery technology. This type of announcement, which communicates a specific business development, operational success, or strategic update outside of mandatory financial reporting periods (like earnings or annual reports), typically falls under general corporate news or regulatory announcements. Since it is not a formal financial report (10-K, IR, ER), a management discussion (MDA), or a specific transaction notice (CAP, TAR, POS), it best fits the general 'Regulatory Filings' category (RNS) as a standard corporate communication, or potentially an Investor Presentation (IP) if it were a slide deck, but here it reads like a news release. Given the options, RNS serves as the best catch-all for non-standard, yet important, corporate updates that are often filed with regulators.
2022-11-17 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.